Research Article
KIF2C Is a Novel Prognostic Biomarker and Correlated with Immune Infiltration in Endometrial Cancer
Table 1
Correlation of KIF2C expression with patients’ clinicopathological features in primary endometrial cancer.
| Parameter | KIF2C expression | value | Low | High |
| Age | 63 (56-71) | 65 (57-72) | 0.06 | Clinical stage | | | <0.01 | FIGO I | 224 | 115 | | FIGO II | 25 | 26 | | FIGO III | 59 | 65 | | FIGO IV | 10 | 19 | | Neoplasm histologic grade | | | <0.01 | G1 | 92 | 6 | | G2 | 98 | 22 | | G3 | 128 | 197 | | Histological type | | | <0.01 | Endometrioid endometrial adenocarcinoma | 277 | 130 | | Mixed serous and endometrioid | 10 | 12 | | Serous endometrial adenocarcinoma | 31 | 83 | |
|
|